Experimental and Molecular Medicine (Jul 2020)

Preclinical pharmacology of a lipophenol in a mouse model of light-induced retinopathy

  • Nicolas Taveau,
  • Aurélie Cubizolle,
  • Laurent Guillou,
  • Nicolas Pinquier,
  • Espérance Moine,
  • David Cia,
  • Vasiliki Kalatzis,
  • Joseph Vercauteren,
  • Thierry Durand,
  • Céline Crauste,
  • Philippe Brabet

DOI
https://doi.org/10.1038/s12276-020-0460-7
Journal volume & issue
Vol. 52, no. 7
pp. 1090 – 1101

Abstract

Read online

Experimental & Molecular Medicine: Vision loss: Shedding light on how to prevent retinal damage Treating retinal damage in both aging and young patients might now be easier, thanks to treatment with a lipophenol, an omega-3 fatty acid linked to an antioxidant. The retina is the part of the eye that senses light, aided by light-sensitive pigments. However, these light-sensitive pigments can be converted by light to toxic byproducts, and in some individuals, these toxic byproducts can accumulate, damaging the retina and leading to vision loss. Philippe Brabet at the Montpellier Institute of Neuroscience in France and co-workers found that lipophenol treatment protected retinal cells from damage in a mouse model of retinal disease, and that a single dose has been effective in preserving vision. These results may help in finding new treatments for retinal diseases such as Stargardt disease and age-related macular degeneration.